CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type, Application, End User, and Region

Description

List of Tables

The global CRISPR & Cas genes market size is expected to reach USD 22.82 billion by 2034, according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share, Trends, Industry Analysis Report: By Type (Products and Services), Application (Biomedical and Agricultural), End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The CRISPR & Cas genes market involves the use of CRISPR-Cas technology for gene editing applications in medicine, agriculture, and biotechnology. This technology allows precise modifications to DNA, enabling advancements in genetic research, disease treatment, and crop improvement. The market is experiencing rapid growth due to its potential to revolutionize personalized medicine, gene therapies, and agricultural practices. Key drivers include increasing investment in genetic research, rising demand for gene therapies, and the need for more sustainable agricultural solutions. However, ethical concerns and regulatory hurdles may affect market expansion.

The rising CRISPR & Cas genes market demand is attributed to advancements in gene-editing technologies, increased investments in genetic research, and expanding applications in healthcare, agriculture, and biotechnology. Key drivers include the potential for CRISPR-based therapies to treat genetic disorders, the growing demand for genetically modified crops with enhanced traits, and the rising need for efficient drug discovery tools. CRISPR & Cas genes market opportunities lie in the development of personalized medicine, gene therapies for rare diseases, and CRISPR's integration into agricultural biotechnology for sustainable food production. Major trends include the shift toward next-generation CRISPR technologies, an increase in clinical trials for gene therapies, and expanding research collaborations between biotech firms and academic institutions.

CRISPR & Cas Genes Market Report Highlights

The products segment holds the largest market share, driven by high demand for CRISPR tools, reagents, and kits for gene-editing research and applications. The services segment is experiencing the highest growth, fueled by increasing outsourcing of CRISPR-related research and development to contract research organizations (CROs).

The biomedical segment dominates the market, driven by the increasing use of CRISPR for gene therapies targeting genetic disorders, cancer, and personalized medicine. The agricultural segment is the fastest-growing, as CRISPR technologies are being leveraged to enhance crop traits and improve food security.

Biotechnology & pharmaceutical companies hold the largest share, investing heavily in CRISPR-based therapies for genetic diseases and drug discovery. The CRO and CDMO segment is growing the fastest, as these organizations play a critical role in advancing clinical trials and gene-editing services for biotech firms.

North America dominates the market, driven by a strong biotechnology sector, significant R&D investments, and regulatory support for gene-editing technologies. Asia-Pacific is the highest-growing region, with rapid adoption of CRISPR technologies in countries like China and India, focusing on both healthcare and agricultural applications.

Polaris Market Research has segmented the CRISPR & Cas Genes market report on the basis of type, application, end user, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

Products
Services

By Application Outlook (Revenue - USD Billion, 2020-2034)

Biomedical
Agricultural

By End User Outlook (Revenue - USD Billion, 2020-2034)

Biotechnology & Pharmaceutical Companies
Academics & Government Research Institutes
Contract Research Organizations (CRO) & CDMOs

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1738

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global CRISPR & Cas Genes Market Insights

4.1. CRISPR & Cas Genes Market - Market Snapshot
4.2. CRISPR & Cas Genes Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in CRISPR-Based Therapeutic End Users
  - 4.2.1.2. Increasing Use of CRISPR in Agricultural BioApplication
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Delivery challenges
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. CRISPR & Cas Genes Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global CRISPR & Cas Genes Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
5.3. Product
- 5.3.1. Global CRISPR & Cas Genes Market, by Product, by Region, 2020-2034 (USD Billion)
5.4. Services
- 5.4.1. Global CRISPR & Cas Genes Market, by Services, by Region, 2020-2034 (USD Billion)

6. Global CRISPR & Cas Genes Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
6.3. Biomedical
- 6.3.1. Global CRISPR & Cas Genes Market, by Biomedical, by Region, 2020-2034 (USD Billion)
6.4. Agricultural
- 6.4.1. Global CRISPR & Cas Genes Market, by Agricultural, by Region, 2020-2034 (USD Billion)

7. Global CRISPR & Cas Genes Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
7.3. Biotechnology & Pharmaceutical Companies
- 7.3.1. Global CRISPR & Cas Genes Market, by Biotechnology & Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
7.4. Academics & Government Research Institutes
- 7.4.1. Global CRISPR & Cas Genes Market, by Academics & Government Research Institutes, by Region, 2020-2034 (USD Billion)
7.5. Contract Research Organizations (CRO) & CDMOs
- 7.5.1. Global CRISPR & Cas Genes Market, by Contract Research Organizations (CRO) & CDMOs, by Region, 2020-2034 (USD Billion)

8. Global CRISPR & Cas Genes Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. CRISPR & Cas Genes Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. CRISPR & Cas Genes Market - North America
- 8.3.1. North America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. CRISPR & Cas Genes Market - U.S.
  - 8.3.4.1. U.S.: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. CRISPR & Cas Genes Market - Canada
  - 8.3.5.1. Canada: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
8.4. CRISPR & Cas Genes Market - Europe
- 8.4.1. Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. CRISPR & Cas Genes Market - UK
  - 8.4.4.1. UK: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. CRISPR & Cas Genes Market - France
  - 8.4.5.1. France: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. CRISPR & Cas Genes Market - Germany
  - 8.4.6.1. Germany: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. CRISPR & Cas Genes Market - Italy
  - 8.4.7.1. Italy: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. CRISPR & Cas Genes Market - Spain
  - 8.4.8.1. Spain: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. CRISPR & Cas Genes Market - Netherlands
  - 8.4.9.1. Netherlands: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. CRISPR & Cas Genes Market - Russia
  - 8.4.10.1. Russia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. CRISPR & Cas Genes Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
8.5. CRISPR & Cas Genes Market - Asia Pacific
- 8.5.1. Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. CRISPR & Cas Genes Market - China
  - 8.5.4.1. China: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. CRISPR & Cas Genes Market - India
  - 8.5.5.1. India: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. CRISPR & Cas Genes Market - Malaysia
  - 8.5.6.1. Malaysia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. CRISPR & Cas Genes Market - Japan
  - 8.5.7.1. Japan: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. CRISPR & Cas Genes Market - Indonesia
  - 8.5.8.1. Indonesia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. CRISPR & Cas Genes Market - South Korea
  - 8.5.9.1. South Korea: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. CRISPR & Cas Genes Market - Australia
  - 8.5.10.1. Australia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. CRISPR & Cas Genes Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
8.6. CRISPR & Cas Genes Market - Middle East & Africa
- 8.6.1. Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. CRISPR & Cas Genes Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. CRISPR & Cas Genes Market - UAE
  - 8.6.5.1. UAE: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. CRISPR & Cas Genes Market - Israel
  - 8.6.6.1. Israel: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. CRISPR & Cas Genes Market - South Africa
  - 8.6.7.1. South Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. CRISPR & Cas Genes Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
8.7. CRISPR & Cas Genes Market - Latin America
- 8.7.1. Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. CRISPR & Cas Genes Market - Mexico
  - 8.7.4.1. Mexico: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. CRISPR & Cas Genes Market - Brazil
  - 8.7.5.1. Brazil: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. CRISPR & Cas Genes Market - Argentina
  - 8.7.6.1. Argentina: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. CRISPR & Cas Genes Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: CRISPR & Cas Genes Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: CRISPR & Cas Genes Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: CRISPR & Cas Genes Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. CRISPR Therapeutics
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Editas Medicine
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Intellia Therapeutics
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Caribou Biosciences
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Sangamo Therapeutics
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Agilent Technologies
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Addgene
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Thermo Fisher Scientific
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Illumina
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Life Technologies
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Precision Biosciences
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Beam Therapeutics
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Cellectis
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Gene Editing Technologies
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Horizon Discovery
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development